70434-82-1 Usage
Description
CP 47,497 is a monophenol cannabimimetic compound that binds the central cannabinoid (CB1) receptor with a Ki value of 2.2 nM. It is equivalent in analgesic potency to Δ9-THC and exhibits other CB biological activities as well.
Chemical Properties
White Solid
Uses
A cannabinoid receptor ligand.
Biological Activity
Potent CB 1 receptor agonist (K i = 2.2 nM). Display 3-28-fold > potency than Δ 9 -THC . Exhibits analgesic, motor depressant, anticonvulsant and hypothermic effects in vivo .
Check Digit Verification of cas no
The CAS Registry Mumber 70434-82-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,4,3 and 4 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 70434-82:
(7*7)+(6*0)+(5*4)+(4*3)+(3*4)+(2*8)+(1*2)=111
111 % 10 = 1
So 70434-82-1 is a valid CAS Registry Number.
InChI:InChI=1/C21H34O2/c1-4-5-6-7-13-21(2,3)17-11-12-19(20(23)15-17)16-9-8-10-18(22)14-16/h11-12,15-16,18,22-23H,4-10,13-14H2,1-3H3/t16-,18+/m1/s1
70434-82-1Relevant articles and documents
A Cannabinoid Derived Prototypical Analgesic
Melvin, Lawrence S.,Johnson, M. Ross,Harbert, Charles A.,Milne, George M.,Weissman, Albert
, p. 67 - 71 (2007/10/02)
The synthesis and analgesic testing of 3-cyclohexanol (1) are described.Prior (SAR) studies led us to conclude that the pyran ring of 9-nor-9β-hydroxyhexahydrocannabinol (HHC) was not necessary for the expression of biological activity in this series of cannabinoids.Analysis of models and the use of molecular mechanics calculations suggested that a simpler compound, such as 1, would possess the biological activity of HHC.Compound 1 was prepared in nine steps from acetonitrile (2).Biological testing in five models of pain shows that compound 1 and morphine are equally potent as analgesics and demonstrates that the pyran ring of HHC is not necessary for biological activity.Further simplification of 1 was pursued by the synthesis of 4--2-pentanol (17), but this derivative exhibits significantly reduced analgesic activity.